Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study. Chen J, Xu C, Wang Q, Lv J, et al. Lung Cancer 2023;183:107315.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen J, Xu C, Wang Q, Lv J, et al. Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study. Lung Cancer 2023;183:107315.
PMID: 37517117